
VantAI Unveils Neo-1, the First AI Model for Rewiring Molecular Interactions in Therapeutic Design
VantAI Unveils Neo-1: A Groundbreaking AI Model for Revolutionary Drug Design VantAI, a cutting-edge biotechnology company, has unveiled Neo-1, a pioneering AI model that is set to transform the future of drug development. Announced at the NVIDIA GTC 2025 conference,…